-
Loading metrics
Open Access
Peer-reviewed
Research Article
Pharmacologic Inhibition of the TGF-β Type I Receptor Kinase Has Anabolic and Anti-Catabolic Effects on Bone
-
Khalid S. Mohammad,
Affiliation Department of Internal Medicine, Division of Endocrinology, University of Virginia, Charlottesville, Virginia, United States of America
⨯ -
Carol G. Chen,
Affiliations Graduate Program in Oral and Craniofacial Sciences, University of California San Francisco, San Francisco, California, United States of America, Department of Orthopaedic Surgery, University of California San Francisco, San Francisco, California, United States of America
⨯ -
Guive Balooch,
Affiliation Department of Materials Science and Engineering, University of California, Berkeley and Materials Science Division, Lawrence Berkeley National Laboratories, Berkeley, California, United States of America
⨯ -
Elizabeth Stebbins,
Affiliation Scios, Inc, Fremont, California, United States of America
⨯ -
C. Ryan McKenna,
Affiliation Department of Internal Medicine, Division of Endocrinology, University of Virginia, Charlottesville, Virginia, United States of America
⨯ -
Holly Davis,
Affiliation Department of Internal Medicine, Division of Endocrinology, University of Virginia, Charlottesville, Virginia, United States of America
⨯ -
Maria Niewolna,
Affiliation Department of Internal Medicine, Division of Endocrinology, University of Virginia, Charlottesville, Virginia, United States of America
⨯ -
Xiang Hong Peng,
Affiliation Department of Internal Medicine, Division of Endocrinology, University of Virginia, Charlottesville, Virginia, United States of America
⨯ -
Daniel H. N. Nguyen,
Affiliation Department of Orthopaedic Surgery, University of California San Francisco, San Francisco, California, United States of America
⨯ -
Sophi S. Ionova-Martin,
Affiliation Scios, Inc, Fremont, California, United States of America
⨯ -
John W. Bracey,
Affiliation Department of Orthopaedic Surgery, Center for Orthopaedic Research, Barton Research Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States of America
⨯ -
William R. Hogue,
Affiliation Department of Orthopaedic Surgery, Center for Orthopaedic Research, Barton Research Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States of America
⨯ -
Darren H. Wong,
Affiliations Scios, Inc, Fremont, California, United States of America, Pfizer RTC, Cambridge, Massachusetts, United States of America
⨯ -
Robert O. Ritchie,
Affiliation Department of Materials Science and Engineering, University of California, Berkeley and Materials Science Division, Lawrence Berkeley National Laboratories, Berkeley, California, United States of America
⨯ -
Larry J. Suva,
Affiliation Department of Orthopaedic Surgery, Center for Orthopaedic Research, Barton Research Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States of America
⨯ -
Rik Derynck,
Affiliations Graduate Program in Oral and Craniofacial Sciences, University of California San Francisco, San Francisco, California, United States of America, Department of Cell and Tissue Biology, University of California San Francisco, San Francisco, California, United States of America, Institute of Regeneration Medicine, University of California San Francisco, San Francisco, California, United States of America
⨯ -
Theresa A. Guise,
Affiliation Department of Internal Medicine, Division of Endocrinology, University of Virginia, Charlottesville, Virginia, United States of America
⨯ - [ ... ],
-
Tamara Alliston
* E-mail: tamara.alliston@ucsf.edu
Affiliations Graduate Program in Oral and Craniofacial Sciences, University of California San Francisco, San Francisco, California, United States of America, Department of Orthopaedic Surgery, University of California San Francisco, San Francisco, California, United States of America, Institute of Regeneration Medicine, University of California San Francisco, San Francisco, California, United States of America
⨯ - [ view all ]
- [ view less ]
Pharmacologic Inhibition of the TGF-β Type I Receptor Kinase Has Anabolic and Anti-Catabolic Effects on Bone
- Khalid S. Mohammad,
- Carol G. Chen,
- Guive Balooch,
- Elizabeth Stebbins,
- C. Ryan McKenna,
- Holly Davis,
- Maria Niewolna,
- Xiang Hong Peng,
- Daniel H. N. Nguyen,
- Sophi S. Ionova-Martin
- Published: April 16, 2009
- https://doi.org/10.1371/journal.pone.0005275